Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Annovis Bio, Inc. (ANVS) had Normalized Pre-Tax Income of $-28.85M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-28.85M |
|
-- |
|
-- |
|
$29.70M |
|
$-29.70M |
|
$0.84M |
|
$-28.85M |
|
|
Normalized Pre-Tax Income |
$-28.85M |
$-28.85M |
|
$-28.85M |
|
$-28.85M |
|
$-28.85M |
|
$-29.70M |
|
$-29.70M |
|
20.55M |
|
20.55M |
|
$-1.40 |
|
$-1.40 |
|
| Balance Sheet Financials | |
$21.08M |
|
-- |
|
-- |
|
$21.08M |
|
$3.64M |
|
-- |
|
$0.59M |
|
$4.23M |
|
$16.85M |
|
$16.85M |
|
$16.85M |
|
27.20M |
|
| Cash Flow Statement Financials | |
$-25.62M |
|
-- |
|
$34.60M |
|
$10.55M |
|
$19.53M |
|
$8.98M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-25.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-171.23% |
|
-171.23% |
|
-136.87% |
|
-171.23% |
|
$0.62 |
|
$-1.25 |
|
$-1.25 |
|